Emerging Paradigms in Insulin Resistance
This book provides a resource for the scientist or medical professional interested in the topic of insulin resistance. With a mix of review and primary data articles, emerging paradigms in insulin resistance are highlighted. The topics are succinctly presented, and distinct viewpoints are represente...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (190 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03024nam-a2200877z--4500 | ||
---|---|---|---|
001 | 993562970804498 | ||
005 | 20231214133054.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 202210s2022 xx |||||o ||| 0|eng d | ||
020 | |a 3-0365-5366-5 | ||
035 | |a (CKB)5670000000391557 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/93248 | ||
035 | |a (EXLCZ)995670000000391557 | ||
041 | 0 | |a eng | |
100 | 1 | |a Burke, Susan J. |4 edt | |
245 | 1 | 0 | |a Emerging Paradigms in Insulin Resistance |
260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (190 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a This book provides a resource for the scientist or medical professional interested in the topic of insulin resistance. With a mix of review and primary data articles, emerging paradigms in insulin resistance are highlighted. The topics are succinctly presented, and distinct viewpoints are represented. An introduction to the Special Issue that provides summaries of the studies included, is provided by the Guest Editor, Dr. Susan Burke, and her colleague at the Pennington Biomedical Research Center, Dr. Jason Collier. | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a epicardial adipose tissue | ||
653 | |a hypertrophy of adipocytes | ||
653 | |a CAD severity | ||
653 | |a adipokines | ||
653 | |a insulin resistance | ||
653 | |a insulin-degrading enzyme | ||
653 | |a pancreas | ||
653 | |a liver | ||
653 | |a insulin receptor | ||
653 | |a glucose transporters | ||
653 | |a acute intermittent porphyria | ||
653 | |a carbohydrate loading therapy | ||
653 | |a hyperinsulinemia | ||
653 | |a fast-acting insulin | ||
653 | |a experimental liver-targeted insulin | ||
653 | |a hyperinsulinaemia | ||
653 | |a osteocalcin | ||
653 | |a beta-hydroxybutyrate | ||
653 | |a phenotype | ||
653 | |a stages | ||
653 | |a serotonin | ||
653 | |a glucagon-like peptide-1 | ||
653 | |a glucagon | ||
653 | |a type 2 diabetes | ||
653 | |a hyperglycaemia | ||
653 | |a apoptosis | ||
653 | |a endoplasmic reticulum stress | ||
653 | |a glucosamine | ||
653 | |a pancreatic β-cell dysfunction | ||
653 | |a ovariectomy | ||
653 | |a raloxifene | ||
653 | |a Negr1 | ||
653 | |a obesity | ||
653 | |a metabolic disease | ||
653 | |a metabolomics | ||
653 | |a glucose intolerance | ||
653 | |a genetic models | ||
653 | |a beta hydroxybutyrate | ||
653 | |a osteoporosis | ||
653 | |a fragility fractures | ||
653 | |a bone mineral density | ||
653 | |a osteocalin | ||
653 | |a vitamin D | ||
653 | |a collagen | ||
653 | |a hydroxyapatite | ||
653 | |a diabetes | ||
653 | |a inflammation | ||
653 | |a thiazolidinedione | ||
776 | |z 3-0365-5365-7 | ||
700 | 1 | |a Burke, Susan J. |4 oth | |
906 | |a BOOK | ||
ADM | |b 2023-12-15 05:41:58 Europe/Vienna |f system |c marc21 |a 2022-11-05 21:33:14 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5340570850004498&Force_direct=true |Z 5340570850004498 |b Available |8 5340570850004498 |